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OBJECTIVE—High-fat diet (HFD)-induced adipose tissue in-
ﬂammation is a critical feature of diet-induced insulin resistance
(IR); however, the contribution of interleukin-1 receptor I
(IL-1RI)-mediated signals to this phenotype has not been deﬁned.
We hypothesized that lack of IL-1RI may ameliorate HFD-induced
IR by attenuating adipose tissue inﬂammation.
RESEARCH DESIGN AND METHODS—Glucose homeostasis
was monitored in chow- and HFD-fed wild-type (WT) and
IL-1RI
2/2 mice by glucose tolerance and insulin tolerance tests.
Macrophage recruitment and cytokine signature of adipose tissue
macrophages was evaluated. Insulin sensitivity and cytokine se-
cretion from adipose explants was quantiﬁed. Cytokine secretion
and adipocyte insulin sensitivity was measured in cocultures of
WT or IL-1RI
2/2 macrophages with 3T3L1 adipocytes. Synergistic
effects of IL-1b with tumor necrosis factor (TNF)-a on inﬂamma-
tion was monitored in WT and IL-1RI
2/2 bone-marrow macro-
phages and adipose explants.
RESULTS—Lean and obese IL-1RI
2/2 animals exhibited en-
hanced glucose homeostasis by glucose tolerance test and insulin
tolerance test. M1/M2 macrophage number in adipose tissue was
comparable between genotypes; however, TNF-a and IL-6 secre-
tion was lower from IL-1RI
2/2 adipose tissue macrophages.
IL-1RI
2/2 adipose exhibited enhanced insulin sensitivity, elevated
pAKT, lower cytokine secretion, and attenuated induction of
phosphorylated signal transducer and activator of transcription 3
and suppressor of cytokine signaling molecule 3 after HFD. Cocul-
ture of WT, but not IL-1RI
2/2 macrophages, with 3T3L1 adipocytes
enhanced IL-6 and TNF-a secretion, reduced adiponectin secre-
tion, and impaired adipocyte insulin sensitivity. TNF-a and IL-1b
potently synergized to enhance inﬂammation in WT macrophages
and adipose, an effect lost in the absence of IL-1RI.
CONCLUSIONS—Lack of IL-1RI protects against HFD-induced
IR coincident with reduced local adipose tissue inﬂammation,
despite equivalent immune cell recruitment. Diabetes 60:1688–
1698, 2011
T
he emergent pandemic of obesity has demanded
greater understanding of associated metabolic
complications, including insulin resistance (IR)
and type 2 diabetes. Immune cell inﬁltration into
adipose during obesity has been documented with initial
inﬁltration of T cells (1–4) followed by macrophages (5,6).
Proinﬂammatory cytokine release from inﬁltrating immune
cells in turn contributes to a chronic state of inﬂammation
(7), with enhanced local secretion of proinﬂammatory
cytokines, interleukin (IL)-1, IL-6, and tumor necrosis
factor (TNF)-a, from the expanding adipose tissue mass
(8–11), which in turn induces adipocyte IR in vitro (12–14).
Furthermore, abrogation of TNF-a signaling alleviates
high-fat diet (HFD)-induced IR in vivo (15), whereas lack
of TLR4 protects against free fatty acid–induced IR (16,17).
These studies suggest that HFD-induced IR is driven by
a pathological immune response; however, the contribu-
tion of IL-1 receptor I (IL-1RI) signaling to this phenotype
has not yet been deciphered, particularly in the context of
adipose tissue biology.
There is much evidence to suggest that IL-1 has a path-
ogenic role in adipose tissue during obesity. Activation of
IL-1b in vivo depends on processing of its pro- to active
form by the NLRP3-caspase-1 inﬂammasome complex
(18). Genetic deletion of NLRP3 (19), or pharmacological
inhibition of caspase-1 (20), confer protection against
obesity-induced IR, effects potentially attributable to re-
duced IL-1b. Downstream IL-1 binds to IL-1RI and acti-
vates nuclear factor (NF)-kB and Jun NH2-terminal kinase
mitogen-activated protein kinase (JNK MAPK) (21,22),
which have been implicated in IR (23,24). Furthermore,
TNF-a, TLR4, and IL-1 signaling pathways converge at the
inhibitor of NFkB kinase (IKK)/NFkB axis (25), with
marked protection of IKK
2/2 mice against IR (26,27). IL-1b
also potently induces production of other proinﬂammatory
cytokines, including IL-6. Both IL-1b and IL-6 induce adi-
pocyte IR in vitro (13,14,28), with IL-1b also inhibiting
adipogenesis (29). IL-6, via activation of JAK2/STAT3, po-
tently induces expression of suppressor of cytokine sig-
naling molecule (SOCS)-3, which is also associated with IR
(30–32). Given this large body of evidence against IL-1, we
hypothesized that lack of IL-1RI would protect against
HFD-induced adipose inﬂammation and improve glucose
homeostasis.
The current study demonstrates that IL-1RI
2/2 mice are
partially protected from HFD-induced IR but not obesity.
The inﬂammatory proﬁle of IL-1RI
2/2 adipose explants,
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ORIGINAL ARTICLEand isolated adipose tissue macrophages (ATMs), was
markedly attenuated, coincident with the inability of TNF-a
and IL-1b to synergize and augment inﬂammation in
IL-1RI
2/2 macrophages and adipose. Attenuated inﬂamma-
tion correlated with improved insulin sensitivity in IL-1RI
2/2
adipose. Furthermore, coculture of IL-1RI
2/2 macrophages
with 3T3L1 adipocytes resulted in a more favorable adipo-
cytokine signature and maintenance of adipocyte insulin
sensitivity compared with coculture with wild-type (WT)
macrophages. This study demonstrates that inﬂammatory
signals transmitted via IL-1RI are primary mediators of
a d i p o s et i s s u ei n ﬂammation during obesity.
RESEARCH DESIGN AND METHODS
Materials. Deoxy-D-glucose 2-[1,2-
3H(N)]
2 was purchased from Perkin-Elmer
Analytical Sciences (Dublin, Ireland). Cell culture material was purchased
from Lonza (Slough, U.K.). All other reagents unless otherwise stated were
from Sigma Aldrich (Dorset, U.K.).
Animals. IL-1RI
2/2 breeding pairs, on a C57BL/6 background, were purchased
from Jackson Laboratories and bred in the University College Dublin for 6–10
generations under speciﬁc pathogen-free conditions. Ethical approval was
obtained from the University College Dublin Ethics Committee, and mice were
maintained according to the regulations of the European Union and the Irish
Department of Health. C57BL/6 WT and IL-1RI
2/2 mice were fed HFD or
a nutrient-matched standard-fat chow diet (45% kcal from palm oil and 10%
kcal from palm oil, respectively; Research Diets, Brunswick, NJ) starting at
age 6 weeks for 12 weeks. Body weight and food intake were recorded weekly.
Metabolic tests were performed at baseline (mice aged 6–8 weeks) and after
12 weeks of chow or HFD.
Intraperitoneal glucose and insulin tolerance tests. Mice were fasted for
6 h and were injected intraperitoneally with 25% (wt/vol) glucose (1.5 g/kg;
B. Braun Medical, Dublin, Ireland) for glucose tolerance test (GTT) or insulin
(0.75 units/kg; Actrapid, Novo Nordisk, Denmark) for insulin tolerance test
(ITT), respectively. Glucose levels were monitored at baseline and at in-
dicated time points after the metabolic challenge via tail-vein blood sampling
using a blood glucose meter from Accu-Chek (Roche, Dublin, Ireland). In-
sulin secretory response was monitored in overnight fasted animals, and
blood samples were collected at indicated times after glucose load (1.5 g/kg).
Insulin levels were measured by enzyme-linked immunosorbent assay
(ELISA).
Body mass composition analysis. Body composition (fat, lean, and water
content) was analyzed using a Bruker’sm i n i s p e cL F 5 0b o d yc o m p o s i t i o n
analyzer according to the manufacturer’s instructions (Bruker Optik,
Ettlingen, Germany).
Stromal vascular fraction isolation and puriﬁcation. Epididymal fat pads
were minced, and adipocytes and stromal vascular fractions were separated by
collagenase (2 mg/mL) digestion. Stromal vascular cells were ﬁltered, blocked
in PBS/2% BSA, and stained with ﬂuorescently labeled antibodies: F4/80-FITC,
CD11B-AF647/PE, CD11C-RPE, CD3-APC, CD4-FITC, CD8-PE, or CD117-PE as
indicated (AbD Serotec, Kidlington, U.K.). Unstained single stains and ﬂuo-
rescence minus one (FMO) controls were used for setting compensations
and gates. Flow cytometry was performed on a Dako CyAn ADP platform
(Beckman-Coulter, Clare, Ireland) and analyzed using Summit v4.3 software.
In separate studies, F4/80
+/CD11B
+ cells were isolated from stromal vascular
fraction using a BD FACSAria cell sorter (BD Biosciences, Oxfordshire, U.K.).
Ex vivo adipose tissue culture. Adipose tissue from WT and IL-1RI
2/2 mice
was harvested at baseline (aged 6–8 weeks) and after HFD. Adipose explants
were placed in 24-well plates (100 mg tissue/well) with 1 mL complete media
(Dulbecco’sm o d i ﬁed Eagle’s medium, 10% FBS, and 1% penicillin/streptomycin)
for 24 h. Media were harvested, and cytokine secretion (TNF-a, IL-6, and IL-1b)
was analyzed by ELISA (Quantikine kits; R&D Systems Europe, Abingdon,
U.K.).
Insulin-stimulated glucose uptake transport into adipose tissue
explants. Lean and obese adipose explants were placed in 24-well plates
(100mgtissue/well)inPBS+0.2%BSAbeforestimulation 6insulin(100nmol/L)
for 15 min. [
3H]Glucose (0.1 mmol/L 2-deoxyglucose + 0.5 mCi/mL [
3H]deoxy-
glucose) was added for 45 min. Tissue was washed, lysed in radioimmuno-
precipitation assay (RIPA) buffer, and homogenized using a tissue lyser
(Qiagen, West Sussex, U.K.). An aliquot of lysate was used for liquid scintil-
lation counting, whereas the remaining aliquot was stored for immunoblot
analysis.
Cellculture. 3T3L1ﬁbroblasts(EuropeanCollectionofCellCultures,Salisbury,
U.K.) were differentiated to adipocytes as previously described (33). Bone
marrow monocytes, isolated from femurs and tibias of WT and IL-1RI
2/2 mice,
were cultured in Dulbecco’sm o d i ﬁed Eagle’s medium supplemented with 10%
FBS, 1% penicillin/streptomycin, and 30% L929 conditioned medium for 7 days
to differentiate to the bone marrow macrophage (BMM) phenotype (34). F4/80
+/
CD11B
+ ATMs were seeded (200,000 cells/1 mL media) in 24-well plates and
incubated in complete media for 24 h in the absence of any stimulus, and media
were harvested for cytokine analysis. NIH-3T3 cells (Panomics, Cambridge,
U.K.) stably transfected with a luciferase reporter construct within the NFkB
promoter region were maintained in complete media + hygromycin B (100 mg/mL)
(Roche, Clare, Ireland).
NIH-3T3 NFkB-luciferase activity assay. Conditioned media from adipose
tissue explants were harvested and incubated with NIH-3T3 cells (1 310
5cells/mL)
for 6 h. Cells were washed in PBS and lysed, and luciferase levels were mea-
sured by luminescence (Promega, Southampton, U.K.).
IL-1b and TNF-a synergistic studies. NIH-3T3 cells were treated with IL-1b
(0.01–10 ng/mL), TNF-a (0.01–10 ng/mL), or IL-1b (0.005–5 ng/mL) and TNF-a
(0.005–5 ng/mL) for 6 h, and NFkB-driven luciferase levels were monitored by
luminescence. The effect of IL-1b and TNF-a on 1) IL-6 protein secretion from
3T3L1 adipocytes (24-h treatment); 2) IL-6, IL-1, SOCS3, and TNF-a mRNA and
IL-6 protein secretion from WT and IL-1RI
2/2 BMMs (24-h treatment); and 3)
IL-6 mRNA and protein secretion in adipose explants (100 mg tissue/mL com-
plete media) (6-h treatment) was monitored.
Coculture study. WT and IL-1RI
2/2 BMMs were seeded on Corning transwell
ﬁlters (0.4 mm, Sigma Aldrich) and LPS-stimulated for 30 min. Lipopolysaccharide-
containing media was removed, cells were washed in PBS, and fresh media were
added. Transwells were transferred to differentiated 3T3L1 adipocytes (day
5 post-differentiation) and left coculture for 5 days. After 72 h, media were
harvested for cytokine analysis and fresh media were added. After co-
culture, insulin-stimulated glucose transport into adipocytes was monitored.
On separate identically treated plates, RNA or protein was harvested for
further analysis.
In vitro glucose uptake assays. Insulin sensitivity of 3T3L1 adipocytes was
monitored in vitro as previously described (35). Brieﬂy, cells were serum
starved for 4 h, and glucose was starved in PBS/0.2% BSA for 30 min before
insulin (100 nmol/L) stimulation for 15 min. [
3H]Deoxyglucose (0.5 mCi/mL
cold glucose [0.1 mmol/L]) was added for 30 min before washing with PBS.
Cells were lysed in RIPA buffer, and [
3H]glucose uptake was measured by
liquid scintillation counting. Remaining lysates were stored for immunoblot
analysis. Fold increase in glucose uptake over basal (non-insulin–stimulated)
is presented.
General laboratory methods. Detailed descriptions of plasma, gene ex-
pression,immunohistochemistry, andimmunoblotanalysis arepresentedinthe
Supplementary Data.
Statistical analysis. Data are reported as mean 6 SEM. For GTT/ITT studies
with multiple time points, we performed two-way repeated-measures ANOVA
to test for differences in means between WT and IL-1RI
2/2 groups. When
ANOVA was signiﬁcant, post hoc Bonferroni corrected t tests were applied.
Area under the curve analysis was performed on GTT and ITT curves using
Graphpad Prism 5 software. For comparison of data between two groups at
a single time point, unpaired t tests were performed. GraphPad Prism 5
(GraphPad Software, San Diego, CA) was used for statistical analyses. Sta-




2/2 mice exhibit greater glucose tolerance and
are partially protected from HFD-induced IR. Glucose
homeostasis was markedly improved in IL-1RI
2/2 com-
pared with WT mice, both at baseline (lean, 6–8 weeks old)
and after 12 weeks of HFD by GTT (Fig. 1A and C) and ITT
(Fig. 1B and D). The GTTs for age-matched chow-fed and
HFD-fed IL-1RI
2/2 mice were equivalent and signiﬁcantly
lower than those for HFD WT mice (Supplementary Fig.
1A and B). Insulin secretion in response to glucose load
was signiﬁcantly higher in lean IL-1RI
2/2 mice than in WT
mice, despite similar fasting levels (Fig. 1E). HFD-fed
IL-1RI
2/2 mice exhibited higher fasting insulin levels
compared with WT mice, but had a similar degree of in-
sulin secretion upon glucose load. There was no difference
in total body weight between IL-1RI
2/2 and WT mice
at baseline or after HFD (Fig. 1F), although epididymal
and visceral adipose tissue depot weight was greater in
obese IL-1RI
2/2 animals (Fig. 1G). Body mass composition
analysis conﬁrmed this increased fat mass (Fig. 1H). The
F.C. MCGILLICUDDY AND ASSOCIATES
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food intake (data not shown) was comparable between
strains. Fasting plasma insulin, leptin, triacylglycerol, and
nonesteriﬁed fatty acids were increased coincident with
reduced levels of adiponectin after HFD in both genotypes
compared with lean counterparts (Table 1). Plasma IL-6
and TNF-a increased with HFD but was not signiﬁcantly
different between genotypes.
Altered immunogenic phenotype of ATMs from
IL-1RI
2/2 mice despite equivalent macrophage
recruitment. Recruitment of macrophages into adipose
tissue was monitored to establish potential mechanisms of
improved glucose homeostasis in IL-1RI
2/2 mice. Whereas
the number of adipose tissue M1 and M2 macrophages
increased with HFD, little difference in recruitment
was evident between genotypes (Fig. 2A and B and
FIG. 1. GTT and ITT in WT and IL-1RI
2/2 mice at baseline and after HFD. A: GTT (1.5 g/kg glucose) in 6-h fasted lean and obese WT and IL-1RI
2/2
animals (●, WT lean; ○, IL-1RI
2/2 lean; ■, WT obese; □, IL-1RI
2/2 obese; ***P < 0.001 with respect to [w.r.t.] IL-1RI
2/2 obese; ###P < 0.001 w.r.t.
IL-1RI
2/2 lean, n =2 7 –31). B: ITT (0.75 units/kg insulin) in 6-h fasted lean and obese WT and IL-1RI
2/2 animals (●, WT lean; ○, IL-1RI
2/2 lean; ■,
WT obese; □, IL-1RI
2/2 obese; *P < 0.05, ***P < 0.001 w.r.t. IL-1RI
2/2 obese, n =2 2 –31). C and D: Area under the curve (AUC) for lean and obese
animals over course of GTT and ITT was calculated and is expressed as arbitrary units (AU) (*P < 0.5, ***P < 0.001 w.r.t. corresponding WT, ##P <
0.01, ###P < 0.001 w.r.t. corresponding lean, n =2 2 –31). E: Insulin secretion response in overnight fasted lean and obese WT and IL-1RI
2/2 animals
after intraperitoneal injection with 1.5 g/kg glucose (*P < 0.05 w.r.t. IL-1RI
2/2 lean; #P < 0.05, ###P < 0.001 w.r.t. corresponding lean). F: Weight
of animals at time of metabolic challenge (###P < 0.001 w.r.t. lean, n =2 2 –31). G: Weight of epididymal adipose tissue (EAT) and visceral adipose
tissue (VAT) depots of lean and obese WT and IL-1RI
2/2 mice (###P < 0.001 w.r.t. lean; *P < 0.05, ***P < 0.001 w.r.t. WT, n =9 –12). H: Body mass
composition analysis in lean and obese animals (*P < 0.05 w.r.t. WT obese, n =8 ) .
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ence in the number of T cells or mast cells (Supplementary
Fig. 2A and B). We next monitored cytokine secretion
from obese-derived WT and IL-1RI
2/2 ATMs and demon-
strated markedly reduced IL-6 and TNF-a secretion by
ATMs from IL-1RI
2/2 compared with WT mice (Fig. 2D
and E).
Attenuated inﬂammatory proﬁle of IL-1RI
2/2 adipose
tissue compared with WT ex vivo. We monitored adi-
pose tissue inﬂammation in explants from lean and obese
WT and IL-1RI
2/2 mice. Secretion of IL-6, TNF-a, and IL-1b
was signiﬁcantly higher from obese adipose explants
compared with lean explants (Fig. 3A, C, and E); however,
cytokine secretion from IL-1RI
2/2 explants was signiﬁ-
cantly reduced compared with WT (Fig. 3A and C). Fur-
thermore, expression of IL-6, TNF-a,a n dSOCS3 mRNA
(Fig. 3B, D, and F) was lower in adipose from IL-1RI
2/2
mice. HFD-mediated phosphorylation of STAT3 and up-
regulation of the SOCS3 protein were also attenuated in
obese IL-1RI
2/2 adipose, whereas there was no difference
in serine-phosphorylated insulin receptor substrate (IRS)-1
(Fig. 3G). Conditioned media from obese adipose explants
induced greater activation of NFkB compared with lean
explants; nonetheless, obese IL-1RI
2/2 media had a signif-
icantly reduced capacity to drive NFkB compared with WT
(Fig. 3H).
IL-1RI
2/2 adipose tissue exhibits greater insulin sen-
sitivity than WT ex vivo. We next sought to estab-
lish whether the attenuated inﬂammatory phenotype of
IL-1RI
2/2 adipose would translate to improved adipose-
speciﬁc insulin sensitivity. Insulin-stimulated [
3H]glucose
uptake was signiﬁcantly higher into adipose of both lean
and obese IL-1RI
2/2 mice compared with WT mice (Fig. 4A),
coincident with increased insulin-induced tyrosine phos-
phorylation of IRS-1 (Fig. 4B). Expression of phosphor-
ylated AKT was also elevated in lean and obese IL-1RI
2/2
adipose; however, levels of phosphorylated insulin re-
ceptor did not differ between strains (Fig. 4C and D).
Expression of IRS-1 and GLUT4 mRNA was signiﬁcantly
higher in lean IL-1RI
2/2 adipose compared with WT; how-
ever, no difference between genotypes was evident after
HFD (Fig. 4E and F). Given this improved insulin-sensitive
phenotype of IL-1RI
2/2 adipose, we further characterized
the direct effect of IL-1b on adipocyte biology in vitro.
Similar to previous studies (13,14), IL-1b dose-dependently
attenuated insulin-stimulated glucose transport into 3T3L1
adipocytes (Supplementary Fig. 3A), coincident with down-
regulation of IRS-1 and GLUT4 mRNA and protein
(Supplementary Fig. 3B and C) and downregulation of
peroxisome proliferator–activated receptor (PPAR)-g,
sterol regulatory element–binding protein (SREBP)-1c,
perilipin, and fatty acid synthase mRNA (Supplementary
Fig. 3D). IL-1b also markedly induced IL-6 mRNA and
protein secretion from 3T3L1 adipocytes (Supplementary
Fig. 3E and F). IL-6 was also capable of inducing adipocyte
IR (Supplementary Fig. 3G) (13) and adipocyte lipolysis
(28).
Altered adipocyte-macrophage cross-talk between
IL-1RI
2/2 macrophages and 3T3L1 adipocytes. Given
the improved insulin-sensitive proﬁle of IL-1RI
2/2 adipose,
we speculated that the reduced immunogenicity of IL-1RI
2/2
macrophages may result in improved cross-talk with resi-
dent adipocytes and preservation of adipocyte functional-
ity. Because the number of ATMs is limited for such
mechanistic studies, we determined the effect of IL-1RI
2/2
versus WT BMMs on adipocyte biology. BMMs from
IL-1RI
2/2 mice had signiﬁcantly reduced basal expression
of IL-6, SOCS3,a n dIL-10 mRNA compared with WT (Fig.
5H). Furthermore, IL-1b induced IL-6, SOCS3, and IL-10
mRNA expression in WT macrophages but had no effect
on IL-1RI
2/2 BMMs (Supplementary Fig. 4A–D). There-
fore, IL-1RI
2/2 BMMs were similarly skewed as the ex vivo
ATMs toward a less inﬂammatory phenotype and thus
represented a relevant macrophage phenotype to de-
termine effects on adipocyte biology.
Coculture of WT BMMs with adipocytes signiﬁcantly
reduced insulin-stimulated glucose transport into adipo-
cytes, while coculture with IL-1RI
2/2 BMM resulted in
partial preservation of adipocyte insulin sensitivity (Fig. 5A
and B). Coculture of WT BMMs, but not IL-1RI
2/2 BMMs,
with adipocytes signiﬁcantly increased IL-6 and TNF-a
secretion, with a concomitant reduction in secretion of
insulin-sensitizing adiponectin (Fig. 5C–E). Furthermore
WT, but not IL-1RI
2/2, BMMs reduced adipocyte GLUT4,
coincident with increased IL-6 mRNA expression (Fig. 5F
and G).
Synergy between IL-1 and TNF signaling pathways
lost in the absence of IL-1RI. To further probe the
mechanisms of attenuated inﬂammation within IL-1RI
2/2
adipose and ATMs, we determined the synergistic effect of
IL-1b and TNF-a in driving adipocyte/macrophage and
adipose tissue inﬂammation, focusing on IL-6, since this
was the most abundant ex vivo adipokine. IL-1b in com-
bination with TNF-a induced greater activation of NFkB
than either cytokine alone (Fig. 6A). There was marked
synergy between IL-1b and TNF-a in promoting IL-6 se-
cretion by adipocytes (Fig. 6B). The synergistic effect of
IL-1b and TNF-a on IL-6 secretion was ablated in BMM
from IL-1RI
2/2 mice (Fig. 6C). TNF-a and IL-1b also syn-
ergized to enhance IL-6, IL-1b,a n dSOCS3, but not TNF-a,
mRNA expression in WT BMMs (Fig. 6D–G), effects that
were also abolished in IL-1RI
2/2 BMMs. We also examined
TABLE 1
Plasma metabolic proﬁle
WT lean WT obese IL-1RI
2/2 lean IL-1RI
2/2 obese
Insulin (mg/L) 0.62 6 0.07 1.66 6 0.19‡ 0.55 6 0.09 2.90 6 0.6‖‡
Leptin (ng/mL) 1,091.1 6 171.2 20,944.3 6 2,623.8‡ 1,152.7 6 254.5 2,5631.1 6 1,178.6‡
TNF-a (ng/mL) 16.93 6 4.88 24.47 6 4.11 8.42 6 3.49 28.07 6 4.69†
IL-6 (ng/mL) 419.1 6 131.7 1,054.2 6 188.8 146.4 6 52.7 1,060.6 6 214.4*
Nonesteriﬁed fatty acid (mmol/L) 1.44 6 0.19 1.79 6 0.4 1.29 6 0.09 2.17 6 0.17*
Triacylglycerol (mmol/L) 0.75 6 0.07 1.84 6 0.41† 1.02 6 0.18 2.09 6 0.2*
Adiponectin (ng/mL) 2,733.9 6 365.4 1,654.1 6 189.9* 3,084.1 6 324.4 1,857.1 6 219.5*
Plasma was isolated from WT and IL-1RI
2/2 mice by cardiac puncture, and levels of metabolic markers were analyzed enzymatically. *P ,
0.05 with respect to (w.r.t.) respective lean. †P , 0.01 w.r.t. respective lean. ‡P , 0.001 w.r.t. respective lean. ‖P , 0.01 w.r.t. WT obese.
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pression and protein secretion ex vivo and demonstrated
a loss of synergy in IL-1RI
2/2 explants (Fig. 6H and I).




Adipose tissue dysfunction due to excessive paracrine in-
ﬂammation is widely recognized as the earliest and argu-
ably most important step in the etiology of obesity-induced
whole-body IR. In the current study, we demonstrate that
signaling through the IL-1RI is a key mediator of
HFD-induced inﬂammation in adipose tissue with partial
protection of IL-1RI
2/2 mice from HFD-induced IR.
There have been conﬂicting ﬁndings to date on the role
of IL-1 during obesity and in the development of diabetes
(36–38), which has been confounded by a central role for
IL-1 in regulation of energy homeostasis and weight
(37,39). García et al. (37) showed IL-1RI
2/2 mice main-
tained on a chow diet develop mature-onset obesity
coincident with moderate glucose intolerance and hyper-
insulinemia. On the contrary, IL-1Ra
2/2 mice exhibit a lean
phenotype with increased energy expenditure and hypo-
insulinemia (39,40). These studies argue for a protective
effect of IL-1 against weight gain; however, differences
in insulin sensitivity in these mouse models could be
solely attributable to differences in weight. In contrast,
NOD mice lacking IL-1RI exhibit slower progression
but not complete inhibition of diabetes (36), an effect
potentially attributable to inhibition of IL-1b–mediated
pancreatic b-cell destruction (41,42). Furthermore, and
consistent with our ﬁndings, treatment of HFD-fed mice
with IL-1Ra improved glucose homeostasis and enhanced
insulin secretion, with protection of b-cells from HFD-
mediated toxicity (38). However, the effect of IL-1Ra on
FIG. 2. Recruitment of WT and IL-1RI
2/2 macrophages into adipose tissue and immunogenic phenotype of isolated ATMs. Adipose tissue was
harvested from WT and IL-1RI
2/2 animals and stromal vascular cells (SVCs) separated from tissue by collagenase digestion. SVCs were labeled
with antibodies to F4/80, CD11B, and CD11C and analyzed by ﬂow cytometry. Cells triple positive (F4/80
+/CD11B
+/CD11C
+) were classiﬁed as M1
macrophages, whereas cells double positive (F4/80
+/CD11B
+/CD11C
2) were classiﬁed as M2 macrophages. Inﬁltration of M1 (A) and M2 (B)
macrophages into adipose tissue was monitored in lean and obese animals and is presented as percentage of total SVC (**P < 0.01, ***P < 0.001
with respect to [w.r.t.] lean, n =1 0 –30). C–E: F4/80
+/CD11B
+ macrophages were sorted from obese adipose tissue and were seeded in complete media
in 24-well plates (200,000 cells/mL media) and left culture for 24 h. Media were harvested and levels of IL-6 (D) and TNF-a (E) were measured by
ELISA (***P < 0.001 w.r.t. WT, n =6 ) .
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assessed. Recent human trials have shown that treatment
with IL-1Ra (anakinra) improves glycemia and b-cell se-
cretory function, coincident with reduced systemic in-
ﬂammation in patients with type 2 diabetes (43). This trial
did not demonstrate improved insulin sensitivity after 13
weeks. Intervention in high-risk prediabetic obese cohorts
may yield more promising results, wherein IL-1RI in-
hibition may delay, if not prevent, development of type 2
diabetes by attenuating adipose inﬂammation and pro-
tecting functional b-cells. Our study adds insight into the
potential initial contribution of IL-1RI signaling during
FIG. 3. Inﬂammatory signature of WT and IL-1RI
2/2 adipose. Adipose explants were cultured for 24 h in serum-containing media (100 mg/mL
media) and levels of proinﬂammatory IL-6 (A), TNF-a (C), and IL-1b secretion into media (E) were measured by ELISA (*P < 0.05, **P < 0.01,
***P < 0.001 with respect to [w.r.t.] WT; #P < 0.05, ##P < 0.01, ###P < 0.001 w.r.t. corresponding lean, n =8 –12). Adipose tissue mRNA levels of
IL-6 (B), TNF-a (D), and SOCS3 (F) were analyzed by real-time PCR (*P < 0.5, **P < 0.01, ***P < 0.001 w.r.t. WT; #P < 0.05, ###P < 0.001 w.r.t.
lean, n =8 ) .G: WT and IL-1RI
2/2 adipose tissue protein lysates at weeks 0 and 12 post-HFD were probed for levels of phosphorylated STAT3,
SOCS3, serine-phosphorylated IRS-1, and b-actin by immunoblot analysis. H: Adipose-tissue conditioned media were applied for 6 h to NIH-3T3
cells stably expressing an NFkB-luciferase promoter-reporter construct to monitor NFkB activity. Levels of NFkB-driven luciferase were quan-
tiﬁed using a luminometer (*P < 0.05 w.r.t. corresponding WT; #P < 0.05, ###P < 0.001 w.r.t. lean AT media, n =8 ) .
F.C. MCGILLICUDDY AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, JUNE 2011 1693early phases of obesity-induced IR, particularly in adipose
tissue.
Our in vivo ﬁndings demonstrate that lack of IL-1RI
partially protects mice from HFD-induced IR, with im-
proved glucose homeostasis and enhanced insulin sensi-
tivity observed in obese IL-1RI
2/2 compared with WT mice.
Plasma concentrations of triacylglycerol, nonesteriﬁed
fatty acid, IL-6, and TNF-a did not differ between strains;
however, consistent with a previous report (37), levels of
insulin were elevated in obese IL-1RI
2/2 mice. This hyper-
insulinemia was not associated with IR and appears to be
an intrinsic characteristic of the animal model given the
converse hypoinsulinemic phenotype of IL-1Ra
2/2 mice
(39). Prediet lean IL-1RI
2/2 mice cleared glucose more
efﬁciently than WT during GTT, which may be attributable
to enhanced insulin secretion in response to glucose load,
together with heightened adipose tissue insulin sensitivity.
This phenotype was age-dependent; glucose tolerance was
equivalent in older chow-fed IL-1RI
2/2 and WT mice, co-
incident with enhanced weight gain in the IL-1RI
2/2 mice as
previously reported (37). Interestingly, HFD-fed IL-1RI
2/2
mice did not develop further IR compared with age-
matched chow-fed IL-1RI
2/2 mice, despite much greater
weight gain, providing further evidence of protection against
HFD-induced IR but not obesity.
Immune cell recruitment into adipose plays a key role
in the etiology of HFD-induced IR (6), prompting us to
speculate that reduced immune cell number in IL-1RI
2/2
adipose may partially account for improved glucose ho-
meostasis. Contrary to our hypothesis, the number of tis-
sue M1/M2 in adipose was not different between IL-1RI
2/2
and WT mice after HFD, demonstrating little role for IL-1
in immune cell chemotaxis. We next speculated the cyto-
kine signature of ATMs may be altered in IL-1RI
2/2 mice.
FIG. 4. Ex vivo evaluation of adipose tissue insulin sensitivity. A: Adipose explants from lean and obese WT and IL-1RI
2/2 mice were harvested and
stimulated 6 insulin (100 nmol/L) ex vivo for 15 min. Tracer [
3H]glucose was added to explants for an additional 45 min. Levels of [
3H]glucose were
measured by liquid scintillation counting. Fold increase in [
3H]glucose transport in response to insulin over basal (non–insulin-stimulated) into
adipose tissue for each individual mouse was calculated and is presented (##P < 0.01, ###P < 0.001 w.r.t. lean; *P < 0.05, **P < 0.01 with
respect to [w.r.t.] WT; $$$P < 0.001 w.r.t. basal, n =8 ) .B–D: Protein lysates were prepared from adipose tissue of lean and obese WT and IL-1RI
2/2
mice after stimulation 6 insulin (100 nmol/L) for 1 h ex vivo. A: Levels of tyrosine phosphorylated IRS-1 in adipose protein lysates were measured
using a PathScan ELISA kit (#P < 0.05 w.r.t. WT lean; *P < 0.05 w.r.t. WT obese; $P < 0.05, $$P < 0.01 w.r.t. basal, n = 8). Levels of phosphorylated
AKT, phosphorylated insulin receptor, whole-cell AKT, and b-actin in lean (C) and obese (D) adipose protein lysates were assessed by immunoblot
analysis. Adipose tissue mRNA levels of IRS-1 (E) and GLUT4 (F) were analyzed by real-time PCR analysis (**P < 0.01, ***P < 0.001 w.r.t. lean;
##P < 0.01, ###P < 0.001 w.r.t. WT, n =8 ) .
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2/2 BMMs with 3T3L1 adipocytes. WT and IL-1RI
2/2 BMMs, seeded on transwell (0.4 mmol/L thickness) inserts,
were stimulated with LPS (100 ng/mL) for 30 min, washed with PBS before addition of fresh media, and transferred to 3T3L1 adipocyte plates
where cells were left to coculture for 5 days. A: The effect of BMMs on insulin (100 nmol/L)-stimulated [
3H]glucose transport into 3T3L1 adi-
pocytes was evaluated. Fold increase in [
3H]glucose transport into adipocytes in response to insulin over basal (non-insulin–stimulated) is pre-
sented (*P < 0.05, ***P < 0.001 with respect to [w.r.t.] individual basal; $$$P < 0.001 w.r.t. control + insulin; ##P < 0.01 w.r.t. WT BMM + insulin,
n =4 ) .B: Protein lysates from cocultured adipocytes stimulated with insulin (100 nmol/L) for 15 min were harvested and probed for levels of
phosphorylated AKT, whole-cell AKT, and b-actin by immunoblot analysis. C–E: Media from cocultured cells were harvested after 72 h and levels
of TNF-a (C), adiponectin (D), and IL-6 (E) were measured by ELISA (*P < 0.05, ***P < 0.001 w.r.t. adipocytes alone, n =4 ) .F and G: Effect of
coculture with WT or IL-1RI
2/2 BMMs on adipocyte IL-6 (F) and Glut4 (G) mRNA expression by real-time PCR (**P < 0.01, ***P < 0.001 w.r.t.
control; #P < 0.05, ###P < 0.001 w.r.t. IL-1RI
2/2 coculture, n =4 ) .H: Baseline inﬂammatory mRNA signature of WT and IL-1RI
2/2 BMMs. Basal
mRNA levels of IL-6, IL-10, TNF-a, SOCS3, SOCS1, caspase 1, and TLR4 in WT and IL-1RI
2/2 BMMs as assessed by real-time PCR (*P < 0.05, **P <
0.01, ***P < 0.001 w.r.t. WT, n =4 ) .
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luciferase promoter-reporter construct were treated with increasing concentrations of IL-1b or TNF-a alone or both in combination for 6 h. Levels of
NFkB-driven luciferase were quantiﬁed using a luminometer (***P < 0.001 with respect to [w.r.t.] control; ###P < 0.001 w.r.t. TNF alone; $$$P <
0.001 w.r.t. either cytokine alone, n =4 ) .B: 3T3L1 adipocytes were treated 6 IL-1b6TNF-a for 24 h, and levels of IL-6 secreted were measured by
ELISA (***P < 0.001 w.r.t. control; $$$P < 0.001 w.r.t. either cytokine alone, n =4 ) .C–G: BMMs were harvested from WT and IL-1RI
2/2 mice and
stimulated 6 IL-1b6TNF-a (10 ng/mL) for 24 h, and levels of IL-6 (C) secreted measured by ELISA and IL-6 (D), SOCS3 (E), IL-1b (F), and
TNFa mRNA (G) were measured by real-time PCR (**P < 0.01, ***P < 0.001 w.r.t. control; #P < 0.05, ##P < 0.01, ###P < 0.001 w.r.t. WT; $P <
0.05, $$P < 0.01, $$$P < 0.001 w.r.t. either cytokine alone, n =3 ) .H and I: Adipose tissue explants (100 mg) were harvested from lean WT and IL-
1RI
2/2 mice and were cultured for 6 h 6 IL-1b6TNF-a (10 ng/mL) and levels of IL-6 secretion (H) and IL-6 mRNA (I) were determined (***P <
0.001 w.r.t. control; #P < 0.05, ###P < 0.001 w.r.t. WT; $$$P < 0.001 w.r.t. either cytokine alone, n =5 ) .
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after 24 h in culture in the absence of any external stim-
ulus, indicative of preactivation within the inﬂamed envi-
ronment of the obese tissue before culture ex vivo. By
contrast, cytokine secretion from IL-1RI
2/2 ATMs was
markedly lower, suggestive of altered immunogenicity. A
recent report demonstrated removal of HFD from WT
obese animals improved insulin sensitivity before reduc-
tion in macrophage number; however, the proinﬂamma-
tory phenotype of these ATMs was markedly attenuated
upon removal of HFD, demonstrating phenotypic plasticity
(44). It is therefore arguable that it is not the number of
macrophages per se that determine poor outcome, but the
activation state, cytokine signature, and functional effects
of ATMs that dictate severity of IR. Upon culture, IL-1RI
2/2
ATMs secreted markedly reduced levels of both TNF-a and
IL-6, and it is thus likely that altered immunogenic phe-
notype of recruited IL-1RI
2/2 immune cells results in im-
proved cross-talk with resident adipocytes and improved
insulin sensitivity. Consistent with this, we demonstrated
improved cytokine cross-talk of IL-1RI
2/2 BMMs with 3T3L1
adipocytes in vitro, coincident with an attenuated effect on
adipocyte insulin sensitivity compared with WT BMMs.
Given the prominent role for adipose tissue dysfunction
in early stages of obesity-induced IR and the attenuated
immunogenic proﬁle of IL-1RI
2/2 ATMs, we next hypoth-
esized that IL-1RI–transduced signals may contribute to
HFD-induced inﬂammation within whole adipose tissue.
Previous ﬁndings in our laboratory highlighted attenuated
inﬂammatory and cellular stress–related proteomic signa-
ture exclusive to adipose tissue rather than skeletal mus-
cle or liver in obese IL-1RI
2/2 mice compared with WT
mice (45). The present work extends our understanding of
the paracrine effect associated with lack of IL-1RI in adi-
pose tissue with reduced IL-6 and TNF-a secretion from
explants coincident with reduced mRNA expression of
TNF-a, IL-6, and SOCS3. Furthermore, we demonstrate
reduced activation of STAT3 coincident with reduced
SOCS3 protein in IL-1RI
2/2 adipose, an effect potentially
attributable to reduced IL-6 secretion. This effect reduced
local adipose tissue inﬂammation in turn correlated with
improved insulin sensitivity of IL-1RI
2/2 adipose ex vivo.
Interestingly, this attenuated inﬂammatory proﬁle was lo-
calized to adipose tissue with equivalent concentrations of
systemic cytokines in IL-1RI
2/2 and WT mice. The dis-
crepancy between systemic and local cytokine levels is
unclear, but may be attributable to almost undetectable
plasma IL-1b levels in WT animals, even with obesity
(46,47), compared with the concentration of IL-1b in
macrophages/adipose tissue.
Whereas IL-1RI signaling clearly plays a nonredun-
dant role during HFD-induced IR, it may be an oversim-
pliﬁcation to attribute the majority of adipose tissue
inﬂammation to the actions of one cytokine. It is much
more likely that adipose-derived cytokines cross-talk to
amplify adipose tissue inﬂammation. Consistent with this
hypothesis, we demonstrated a potent synergistic effect of
the major adipocytokines IL-1b and TNF-a in enhancing
NFkB activation and adipose IL-6 protein secretion. This
synergistic effect on macrophage and adipose IL-6 secre-
tion was lost in the absence of IL-1RI. Furthermore, the
ability of TNF-a to induce IL-6 secretion was blunted in
IL-1RI
2/2 adipose, suggesting that TNF-a–induced IL-6 is
in part mediated via IL-1. Remarkably, TNF-a and IL-1b
synergized to enhance IL-1b mRNA expression in WT
BMMs far beyond the effects of either cytokine alone,
suggesting that these cytokines work in concert to create
a positive feedback loop. Interestingly, TNF-a mRNA ex-
pression was not enhanced, suggesting differential regula-
tory mechanisms for TNF-a mRNA. These ﬁndings suggest
that blocking IL-1 signaling not only ameliorates the ad-
verse effects of IL-1 on adipocyte/macrophage biology, but
also prevents the synergy between TNF-a and IL-1b, thus
alleviating adipose tissue inﬂammation.
Recent reports demonstrating activation of the NLRP3
inﬂammasome following an HFD and protection of
inﬂammasome-compromised mice against HFD-induced IR
(19,20) have given new insight into the upstream mecha-
nisms through which IL-1 is elevated during obesity. We
have focused on the downstream consequences of IL-1RI
signaling within adipose tissue during an HFD and have
demonstrated that IL-1RI
2/2 mice are protected against
HFD-induced IR coincident with attenuated adipose tissue
and ATM inﬂammation. There are numerous local cellular
targets and functional consequences of IL-1 released from
adipose tissue, including preadipocytes (inhibition of
adipogenesis), mature adipocytes (induction of IR), and
inﬁltrated immune cells (enhanced cytokine secretion), all
of which may contribute to adipose tissue IR. However,
our study is limited in its ability to distinguish whether lack
of IL-1RI signaling in immune cells or in adipocyte/
preadipocyte fractions is primarily responsible for this im-
proved phenotype. Metabolic studies in animals with ei-
ther immune-speciﬁc or adipocyte-speciﬁc deletion of
IL-1RI would in turn provide greater insight into these
mechanistic queries.
In conclusion, we ascribe a pathogenic role to IL-1RI–
mediated signals during HFD-induced adipose tissue dys-
function and IR. Improved glucose homeostasis in IL-1RI
2/2
mice correlated with a marked reduction in local adipose
inﬂammation, with altered ATM cytokine signatures and
pronounced attenuation in both IL-6 secretion and activa-
tion of the IL-6 regulated proteins STAT3 and SOCS3. Loss
of synergy between TNF-a and IL-1b in IL-1RI
2/2 adipose
m a yi nt u r nh a v ec o n t r i b u t e dt ot h i sa t t e n u a t e di n ﬂammatory
proﬁle. This study highlights the critical and nonredundant
contribution of IL-1 to the medley of proinﬂammatory
insulin-desensitizing signals relevant to obesity-induced IR.
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